GENEVA, Feb. 24 -- ASCIDIAN THERAPEUTICS, INC. (80 Guest StreetBoston, Massachusetts 02135) filed a patent application (PCT/US2025/041807) for "MSH3 MODULATORY MOLECULES" on Aug 13, 2025. With publication no. WO/2026/039524, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PAVIS, Anika (c/o Ascidian Therapeutics, Inc.80 Guest StreetBoston, Massachusetts 02135), DOI, Akiko (c/o Ascidian Therapeutics, Inc.80 Guest StreetBoston, Massachusetts 02135)

Abstract: MSH3 splice modulators and constructs encoding same are described ...